Manufacturer of paracetamol combination products will now have to print a
 statutory warning on the drug boxes stating "Taking more than the daily dose of
paracetamol may cause serious liver damage or allergic reactions".

Besides, the Drug Controller General of India has asked the state licensing authorities
 ( Food and Drug Administration) not to grant fresh licenses or renewals to products with
combination of paracetamol, containing more than 325 mg per tablet or capsule.
The decision of limiting acetaminophen (paracetamol) comes in the wake of the United State's FDA
 issuing a similar note on January 13,2011.
The validity period for renewing manufacturing licence is five years.
The directorate of health services, Central Drugs Standard Control Organization, had issued
the notification last month.
The order was based on the decision of the Drug Technical Advisory
Board that paracetamol is known to have liver toxicity.